This non-toxic engineered nanoparticle evidenced the selective modulation of Tregs homeostasis through mechanisms such as maintenance of TNF-TNFR2 interaction, targeting CD103+ DCs, and expanding the proliferative rate of Tregs, thus decreasing the susceptibility to allergic disease. The gene discussed is TNFRSF1B; the disease is allergic disease.